Template
Template
Sep 02, 2024
The revised Quality Assurance for Health policy and procedures result from valuable lessons learned from implementing the 2018 policy version during the height of the COVID-19 pandemic. It serves to assure the safety of all health products procured by UNDP, in line with international best practices. The significant changes in the revised policy include the following:
1. Requirements for PPE, in-vitro diagnostics, and medical gas systems.
2. Recognition of market clearances and manufacturer certificates issued by Conformity Assessment Bodies that are members of the International Accreditation Forum for Class A medical devices.
3. Roles and responsibilities of the UNDP QA in CO/RBx managed procurement
4. Establish a committee to conduct risk-benefit assessments of health products in complex situations.
4. Recognition of QA approvals made by other UN agencies and other international organisations.
5. Requirements for emergency assessments and approvals in response to pandemics declared by WHO and levels of crises declared by UNDP.
5. Clarifies requirements for the use of Research Use Only products used in medical laboratory settings.
6. Recognition of health product market authorisation and other regulatory activities of WHO Listed National Regulatory Authorities.
7. Recognition of health product market authorisation and other regulatory activities of National Regulatory Authorities with WHO maturity Level 3 and 4 in specific conditions.
Aug 26, 2024
The Dependency Status and Allowances policy has been updated to reflect an increase in the amount of the special dependency allowance for international staff.
Jul 10, 2024
This change to the Performance Management and Development policy introduces an additional option in the Annual Performance Review (APR) overall rating scale. Previously, the overall performance rating scale options included: ‘Successfully meets performance expectations’ and ‘Does not fully meet performance expectations’. From 2024 onwards, an additional option will be included, namely: ‘Partially meets performance expectations’.
The Talent Management Committee (TMC) can now review both ‘Partially meets performance expectations’ and ‘Does not meet performance expectations’ ratings under dispute. And both ratings, should staff members disagree with the TMC outcome, can be rebutted through a standard rebuttal process.
The introduction of the new rating scale has also resulted in some changes to the Performance Improvement Process for underperformance related to timelines and procedures. Supervisors can still initiate a Performance Improvement Plan (PIP) early in the year if needed, but it now becomes mandatory if the Mid-Term Review indicates significant improvement is necessary. PIPs must also be implemented following Annual Performance Reviews that result in 'Partially meets' or 'Does not meet' ratings.
If performance does not improve as expected or if the supervisee refuses to comply with the PIP, their appointment may be terminated or not renewed. A supervisee can have up to two consecutive PIPs for a 'Partially meets' rating and one PIP for a 'Does not meet' rating unless a waiver is obtained. Supervisors are responsible for developing PIPs and for providing ongoing support and feedback throughout the process.
Jul 09, 2024
The following clarification and editorial updates have been implemented:
Jul 09, 2024
The following clarification and editorial updates have been implemented:
The following clarification and editorial updates have been implemented:
Jul 09, 2024
The following clarification and editorial updates have been implemented:
Jun 25, 2024
This update is to extend the duration of the Service Contract policy to 31 December 2024 to cover the transitional period of partner personnel currently on Service Contracts who will transition to Partner Personnel Services Agreement by 31 December 2024.
Template